| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| JUNO | Juno Therapeutics, Inc. | Azelby Robert | EVP & Chief Commercial Officer | Feb 12, 2018 | Sale | $85.55 | 4,159 | 355,802 | 89,612 | Feb 15, 2018, 07:31 PM | |
| JUNO | Juno Therapeutics, Inc. | Azelby Robert | EVP & Chief Commercial Officer | Feb 12, 2018 | Sale | $85.55 | 4,157 | 355,631 | 89,614 | Feb 14, 2018, 07:24 PM | |
| JUNO | Juno Therapeutics, Inc. | Azelby Robert | EVP & Chief Commercial Officer | Feb 08, 2018 | Option Exercise | $21.84 | 3,497 | 76,376 | 97,268 | Feb 09, 2018, 07:27 PM | |
| JUNO | Juno Therapeutics, Inc. | Azelby Robert | EVP & Chief Commercial Officer | Feb 08, 2018 | Sale | $85.77 | 3,497 | 299,938 | 93,771 | Feb 09, 2018, 07:27 PM | |
| JUNO | Juno Therapeutics, Inc. | Azelby Robert | EVP & Chief Commercial Officer | Feb 07, 2018 | Option Exercise | $85.49 | 2,700 | 230,823 | 93,771 | Feb 09, 2018, 07:27 PM | |
| JUNO | Juno Therapeutics, Inc. | Azelby Robert | EVP & Chief Commercial Officer | Feb 01, 2018 | Option Exercise | $51.76 | 4,167 | 215,684 | 100,638 | Feb 02, 2018, 07:26 PM | |
| JUNO | Juno Therapeutics, Inc. | Azelby Robert | EVP & Chief Commercial Officer | Feb 01, 2018 | Sale | $85.78 | 4,167 | 357,445 | 96,471 | Feb 02, 2018, 07:26 PM | |
| JUNO | Juno Therapeutics, Inc. | Azelby Robert | EVP & Chief Commercial Officer | Jan 22, 2018 | Option Exercise | $51.76 | 102,539 | 5,307,418 | 173,371 | Jan 24, 2018, 06:46 PM | |
| JUNO | Juno Therapeutics, Inc. | Azelby Robert | EVP & Chief Commercial Officer | Jan 22, 2018 | Sale | $86.25 | 102,539 | 8,843,989 | 70,832 | Jan 24, 2018, 06:46 PM | |
| JUNO | Juno Therapeutics, Inc. | Azelby Robert | EVP & Chief Commercial Officer | Jan 17, 2018 | Option Exercise | $21.15 | 29,131 | 616,076 | 99,963 | Jan 19, 2018, 09:00 PM | |
| JUNO | Juno Therapeutics, Inc. | Azelby Robert | EVP & Chief Commercial Officer | Jan 17, 2018 | Sale | $68.61 | 29,131 | 1,998,603 | 78,822 | Jan 19, 2018, 09:00 PM | |
| JUNO | Juno Therapeutics, Inc. | Azelby Robert | EVP & Chief Commercial Officer | Dec 18, 2017 | Sale | $44.96 | 1,816 | 81,647 | 70,832 | Dec 20, 2017, 04:37 PM | |
| JUNO | Juno Therapeutics, Inc. | Azelby Robert | EVP & Chief Commercial Officer | Nov 08, 2017 | Option Exercise | $55.98 | 684 | 38,290 | 72,648 | Nov 09, 2017, 07:32 PM | |
| JUNO | Juno Therapeutics, Inc. | Azelby Robert | EVP & Chief Commercial Officer | Nov 02, 2017 | Sale | $54.95 | 6,666 | 366,297 | 73,332 | Nov 03, 2017, 07:30 PM | |
| JUNO | Juno Therapeutics, Inc. | Azelby Robert | EVP & Chief Commercial Officer | Nov 02, 2017 | Option Exercise | $25.29 | 6,666 | 168,583 | 79,998 | Nov 03, 2017, 07:30 PM | |
| JUNO | Juno Therapeutics, Inc. | Azelby Robert | EVP & Chief Commercial Officer | Sep 13, 2017 | Sale | $44.95 | 12,850 | 577,608 | 37,439 | Sep 14, 2017, 07:31 PM | |
| JUNO | Juno Therapeutics, Inc. | Azelby Robert | EVP & Chief Commercial Officer | Aug 29, 2017 | Sale | $39.95 | 12,869 | 514,117 | 50,289 | Aug 31, 2017, 07:44 PM | |
| JUNO | Juno Therapeutics, Inc. | Azelby Robert | EVP & Chief Commercial Officer | Nov 10, 2016 | Sale | $24.14 | 12,921 | 311,848 | 35,719 | Nov 10, 2016, 08:56 PM |
Menu